WEBULL
News
EW
86.95
+0.12%
0.10
Analysts Are Bullish on These Healthcare Stocks: Natera (NTRA), Immunome (IMNM)
TipRanks · 13h ago
EW Wins FDA Approval for SAPIEN M3 as First Transseptal TMVR Therapy
NASDAQ · 3d ago
How Well Is Boston Scientific Placed for Long-Term Endoscopy Growth?
NASDAQ · 5d ago
The Zacks Analyst Blog Highlights Cardinal Health, Medtronic, Intuitive Surgical and Edwards Lifesciences
NASDAQ · 6d ago
Edwards Lifesciences wins FDA nod for SAPIEN M3 TMVR system
Seeking Alpha · 6d ago
Edwards Lifesciences receives FDA approval for SAPIEN M3 mitral valve system
TipRanks · 6d ago
Edwards Lifesciences Says FDA Approves SAPIEN M3 Mitral Valve Replacement System For Treatment Of Mitral Regurgitation
Benzinga · 6d ago
Edwards Lifesciences Advances Smart Surgery Monitoring With Completed SMART TRENDS Study
TipRanks · 12/22 16:30
4 Large-Cap MedTech Stocks to Keep Winning Streaks Alive in 2026
NASDAQ · 12/22 16:07
Weekly Report: what happened at EW last week (1215-1219)?
Weekly Report · 12/22 09:46
How JP Morgan’s Upgrade and 2026 Conference Spotlight Will Impact Edwards Lifesciences (EW) Investors
Simply Wall St · 12/22 03:21
Edwards Lifesciences upgraded at JP Morgan on TAVR, TMTT strength
Seeking Alpha · 12/18 19:03
Edwards Lifesciences Raised to Overweight From Neutral by JP Morgan
Dow Jones · 12/18 13:50
Edwards Lifesciences Price Target Raised to $100.00/Share From $90.00 by JP Morgan
Dow Jones · 12/18 13:50
JP Morgan Upgrades Edwards Lifesciences to Overweight, Raises Price Target to $100
Benzinga · 12/18 13:40
Edwards Lifesciences upgraded to Overweight from Neutral at JPMorgan
TipRanks · 12/18 10:10
Edwards Lifesciences: Buy Rating on Structural Heart Leadership, Accelerating TAVR/TMTT Growth, and Durable Double‑Digit Upside
TipRanks · 12/18 10:05
Stocks Rebound on Strength in Chip Stocks and a Benign US CPI Report
Barchart · 12/18 08:57
Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
Barchart · 12/18 06:05
RBC Capital Reaffirms Their Buy Rating on Edwards Lifesciences (EW)
TipRanks · 12/18 01:47
More
Webull provides a variety of real-time EW stock news. You can receive the latest news about Edwards Lifesciences Corp through multiple platforms. This information may help you make smarter investment decisions.
About EW
Edwards Lifesciences Corporation is the global structural heart company. The Company partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. It provides transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. TAVR category includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra and the Edwards SAPIEN 3 Ultra RESILIA systems. TMTT category includes the PASCAL Precision transcatheter repair system, EVOQUE tricuspid valve replacement system and Cardioband tricuspid valve reconstruction system. Its INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. It is managed in various geographical regions, such as United States, Europe, Japan and Rest of World.